|
|
||||||||




*
Department of Medicine, Division of Rheumatology, and
Department of Immunology and Howard Hughes Medical Institute, University of Washington, Seattle, WA 98195
The enzymes that degrade proteins to peptides for presentation on MHC class II molecules are poorly understood. The cysteinal lysosomal proteases, cathepsin L (CL) and cathepsin S (CS), have been shown to process invariant chain, thereby facilitating MHC class II maturation. However, their role in Ag processing is not established. To examine this issue, we generated embryonic fibroblast lines that express CL, CS, or neither. Expression of CL or CS mediates efficient degradation of invariant chain as expected. Ag presentation was evaluated using T cell hybridoma assays as well as mass spectroscopic analysis of peptides eluted from MHC class II molecules. Interestingly, we found that the majority of peptides are presented regardless of CL or CS expression, although these proteases often alter the relative levels of the peptides. However, for a subset of Ags, epitope generation is critically regulated by CL or CS. This result suggests that these cysteinal proteases participate in Ag processing and generate qualitative and quantitative differences in the peptide repertoires displayed by MHC class II molecules.
This article has been cited by other articles:
![]() |
E. M. Johnson, J. D. Doyle, J. D. Wetzel, R. P. McClung, N. Katunuma, J. D. Chappell, M. K. Washington, and T. S. Dermody Genetic and Pharmacologic Alteration of Cathepsin Expression Influences Reovirus Pathogenesis J. Virol., October 1, 2009; 83(19): 9630 - 9640. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Nepal, B. Vesosky, J. Turner, and P. Bryant DM, but not cathepsin L, is required to control an aerosol infection with Mycobacterium tuberculosis J. Leukoc. Biol., October 1, 2008; 84(4): 1011 - 1018. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Weaver, C. A. Lazarski, K. A. Richards, F. A. Chaves, S. A. Jenks, P. R. Menges, and A. J. Sant Immunodominance of CD4 T Cells to Foreign Antigens Is Peptide Intrinsic and Independent of Molecular Context: Implications for Vaccine Design J. Immunol., September 1, 2008; 181(5): 3039 - 3048. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. L. Podolin, B. J. Bolognese, D. C. Carpenter, T. G. Davis, R. A. Johanson, J. H. Fox, E. Long III, X. Dong, R. W. Marquis, S. M. LoCastro, et al. Inhibition of Invariant Chain Processing, Antigen-Induced Proliferative Responses, and the Development of Collagen-Induced Arthritis and Experimental Autoimmune Encephalomyelitis by a Small Molecule Cysteine Protease Inhibitor J. Immunol., June 15, 2008; 180(12): 7989 - 8003. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Mihelic, A. Dobersek, G. Guncar, and D. Turk Inhibitory Fragment from the p41 Form of Invariant Chain Can Regulate Activity of Cysteine Cathepsins in Antigen Presentation J. Biol. Chem., May 23, 2008; 283(21): 14453 - 14460. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Marturano, R. Longhi, V. Russo, and M. P. Protti Endosomal Proteases Influence the Repertoire of MAGE-A3 Epitopes Recognized In vivo by CD4+ T Cells Cancer Res., March 1, 2008; 68(5): 1555 - 1562. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kakehashi, T. Nishioku, T. Tsukuba, T. Kadowaki, S. Nakamura, and K. Yamamoto Differential Regulation of the Nature and Functions of Dendritic Cells and Macrophages by Cathepsin E J. Immunol., November 1, 2007; 179(9): 5728 - 5737. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. P. M. Lutgens, K. B. J. M. Cleutjens, M. J. A. P. Daemen, and S. Heeneman Cathepsin cysteine proteases in cardiovascular disease FASEB J, October 1, 2007; 21(12): 3029 - 3041. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Sa-Nunes, A. Bafica, D. A. Lucas, T. P. Conrads, T. D. Veenstra, J. F. Andersen, T. N. Mather, J. M. C. Ribeiro, and I. M. B. Francischetti Prostaglandin E2 Is a Major Inhibitor of Dendritic Cell Maturation and Function in Ixodes scapularis Saliva J. Immunol., August 1, 2007; 179(3): 1497 - 1505. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. A. Bulynko, L. C. Hsing, R. W. Mason, D. J. Tremethick, and S. A. Grigoryev Cathepsin L stabilizes the histone modification landscape on the y chromosome and pericentromeric heterochromatin. Mol. Cell. Biol., June 1, 2006; 26(11): 4172 - 4184. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M Nepal, S. Mampe, B. Shaffer, A. H Erickson, and P. Bryant Cathepsin L maturation and activity is impaired in macrophages harboring M. avium and M. tuberculosis Int. Immunol., June 1, 2006; 18(6): 931 - 939. [Abstract] [Full Text] [PDF] |
||||
![]() |
I-C. Huang, B. J. Bosch, F. Li, W. Li, K. H. Lee, S. Ghiran, N. Vasilieva, T. S. Dermody, S. C. Harrison, P. R. Dormitzer, et al. SARS Coronavirus, but Not Human Coronavirus NL63, Utilizes Cathepsin L to Infect ACE2-expressing Cells J. Biol. Chem., February 10, 2006; 281(6): 3198 - 3203. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Wang, R. M. Baron, G. Zhu, M. Joo, J. W. Christman, E. S. Silverman, M. A. Perrella, R. J. Riese, and M. Cernadas PU.1 Regulates Cathepsin S Expression in Professional APCs J. Immunol., January 1, 2006; 176(1): 275 - 283. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Zavasnik-Bergant, U. Repnik, A. Schweiger, R. Romih, M. Jeras, V. Turk, and J. Kos Differentiation- and maturation-dependent content, localization, and secretion of cystatin C in human dendritic cells J. Leukoc. Biol., July 1, 2005; 78(1): 122 - 134. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. J. Beswick, D. A. Bland, G. Suarez, C. A. Barrera, X. Fan, and V. E. Reyes Helicobacter pylori Binds to CD74 on Gastric Epithelial Cells and Stimulates Interleukin-8 Production Infect. Immun., May 1, 2005; 73(5): 2736 - 2743. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. M. Chain, P. Free, P. Medd, C. Swetman, A. B. Tabor, and N. Terrazzini The Expression and Function of Cathepsin E in Dendritic Cells J. Immunol., February 15, 2005; 174(4): 1791 - 1800. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Beers, A. Burich, M. J. Kleijmeer, J. M. Griffith, P. Wong, and A. Y. Rudensky Cathepsin S Controls MHC Class II-Mediated Antigen Presentation by Epithelial Cells In Vivo J. Immunol., February 1, 2005; 174(3): 1205 - 1212. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Yang, M. Kala, B. G. Scott, E. Goluszko, H. A. Chapman, and P. Christadoss Cathepsin S Is Required for Murine Autoimmune Myasthenia Gravis Pathogenesis J. Immunol., February 1, 2005; 174(3): 1729 - 1737. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Thai, G. Moine, M. Desmadril, D. Servent, J.-L. Tarride, A. Menez, and M. Leonetti Antigen Stability Controls Antigen Presentation J. Biol. Chem., November 26, 2004; 279(48): 50257 - 50266. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. Golden, J. A. Bahe, W. T. Lucas, M. L. Nibert, and L. A. Schiff Cathepsin S Supports Acid-independent Infection by Some Reoviruses J. Biol. Chem., March 5, 2004; 279(10): 8547 - 8557. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Grechez-Cassiau, S. Panda, S. Lacoche, M. Teboul, S. Azmi, V. Laudet, J. B. Hogenesch, R. Taneja, and F. Delaunay The Transcriptional Repressor STRA13 Regulates a Subset of Peripheral Circadian Outputs J. Biol. Chem., January 9, 2004; 279(2): 1141 - 1150. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Roper, R. D. McAllister, J. E. Biggins, S. D. Michael, S. H. Min, K. S. K. Tung, S. B. Call, J. Gao, and C. Teuscher Aod1 Controlling Day 3 Thymectomy-Induced Autoimmune Ovarian Dysgenesis in Mice Encompasses Two Linked Quantitative Trait Loci with Opposing Allelic Effects on Disease Susceptibility J. Immunol., June 15, 2003; 170(12): 5886 - 5891. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Bania, E. Gatti, H. Lelouard, A. David, F. Cappello, E. Weber, V. Camosseto, and P. Pierre Human cathepsin S, but not cathepsin L, degrades efficiently MHC class II-associated invariant chain in nonprofessional APCs PNAS, May 27, 2003; 100(11): 6664 - 6669. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Greiner, A. Lautwein, H. S. Overkleeft, E. Weber, and C. Driessen Activity and subcellular distribution of cathepsins in primary human monocytes J. Leukoc. Biol., February 1, 2003; 73(2): 235 - 242. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Ye, P. W. Finn, R. Sweeney, E. K. Bikoff, and R. J. Riese MHC Class II-Associated Invariant Chain Isoforms Regulate Pulmonary Immune Responses J. Immunol., February 1, 2003; 170(3): 1473 - 1480. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Beers, K. Honey, S. Fink, K. Forbush, and A. Rudensky Differential Regulation of Cathepsin S and Cathepsin L in Interferon {gamma}-treated Macrophages J. Exp. Med., January 20, 2003; 197(2): 169 - 179. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Honey, T. Nakagawa, C. Peters, and A. Rudensky Cathepsin L Regulates CD4+ T Cell Selection Independently of Its Effect on Invariant Chain: A Role in the Generation of Positively Selecting Peptide Ligands J. Exp. Med., May 20, 2002; 195(10): 1349 - 1358. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |